T&L Co Ltd (340570.KS)

KSC Basic Materials Chemicals - Specialty

39.4

ValueMarkers Composite Index

Top 13%#39,338 of 45,190

DCF data not available

Piotroski

0/9

Weak

Beneish

Altman

DCF Value

N/A

ROIC

P/E

9.8

Value

Unlock Full Analysis · Free Trial

Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

T&L Co.,Ltd produces and sells medical products. The Company manufactures and sells wound healing materials, fracture treatment fixation materials, medical consumables, and other products. T&L markets its products throughout Korea.

CEO: Yoon-So Choi220 employeesKRwww.tnl.co.kr

Deep Dive Analysis

DCF Analysis

Intrinsic value estimate, margin of safety, and key valuation metrics.

Graham: $0.00

Piotroski F-Score

9-point financial strength test across profitability, leverage, and efficiency.

F-Score: 0/9

Quality Triple Check

Piotroski F-Score + Altman Z-Score + Beneish M-Score combined assessment.

F: 0/9

Valuation Analysis

Complete multiples breakdown - P/E, P/B, EV/EBITDA, yield metrics, and intrinsic value.

P/E: 9.8P/B: 2.2EV/EBITDA: 6.5